Minerva Neurosciences On April 10, Got Notice From Nasdaq That Company Was Not In Compliance With Nasdaq's Listing Rule
Portfolio Pulse from Benzinga Newsdesk
Minerva Neurosciences received a notice from Nasdaq on April 10, indicating that the company is not in compliance with Nasdaq's listing rules, according to an SEC filing.
April 12, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Minerva Neurosciences was notified by Nasdaq of non-compliance with listing rules.
Receiving a notice of non-compliance from Nasdaq is a significant regulatory issue that can affect investor confidence and the stock's market standing. Such notices often lead to negative perceptions about a company's financial health or governance, potentially causing a short-term decline in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100